Skip to content

Safety and Performance Study of the CardioGard Cannula

A Study to Collect Additional Information Related to the Safety and Performance of the CardioGard Cannula

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01554709
Enrollment
71
Registered
2012-03-15
Start date
2012-03-31
Completion date
2014-05-31
Last updated
2014-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Replacement

Keywords

bypass, cannula

Brief summary

The objective of the study is to collect additional information related to the safety and performance of the CardioGard Cannula during bypass procedures.

Interventions

DEVICEAortic Cannulas (CardioGard)

Comparison of aortic cannulas during by pass surgery

Sponsors

CardioGard Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* AVR (Aortic Valve Replacement), AVR+CABG (Coronary Artery Bypass Surgery) * Non pregnant female

Exclusion criteria

* Contraindication for open heart surgery under bypass machine * Emergency Operation

Design outcomes

Primary

MeasureTime frameDescription
DWI- Diffusion Weighted ImagingThe outcome measure is assessed in average a week after the surgerydiffusion weighted magnetic resonance imaging (DW-MRI)

Secondary

MeasureTime frame
TCD- Transcranial DopplerThe Outcome measure is assessed during the surgery

Countries

Germany, Israel, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026